Wasnick, R.* ; Korfei, M.* ; Piskulak, K.* ; Henneke, I.* ; Wilhelm, J.* ; Mahavadi, P.* ; Dartsch, R.C.* ; von der Beck, D.* ; Koch, M.* ; Shalashova, I.* ; Weiss, A.R.* ; Klymenko, O.* ; Askevold, I.* ; Fink, L.* ; Witt, H.* ; Hackstein, H.* ; El Agha, E.* ; Bellusci, S.* ; Klepetko, W.* ; Königshoff, M. ; Eickelberg, O.* ; Schermuly, R.T.* ; Braun, T.* ; Seeger, W.* ; Ruppert, C.* ; Guenther, A.*
Notch1 induces defective epithelial surfactant processing and pulmonary fibrosis.
Am. J. Respir. Crit. Care Med. 207, 283-299 (2023)
Rationale: Although type II alveolar epithelial cells (AEC2s) are chronically injured in idiopathic pulmonary fibrosis (IPF), they contribute to epithelial regeneration in IPF. Objectives: We hypothesized that Notch signaling may contribute to AEC2 proliferation, dedifferentiation characterized by loss of surfactant processing machinery, and lung fibrosis in IPF. Methods: We applied microarray analysis, kinome profiling, flow cytometry, immunofluorescence analysis, western blotting, quantitative PCR, and proliferation and surface activity analysis to study epithelial differentiation, proliferation, and matrix deposition in vitro (AEC2 lines, primary murine/human AEC2s), ex vivo (human IPF-derived precision-cut lung slices), and in vivo (bleomycin and pepstatin application, Notch1 [Notch receptor 1] intracellular domain overexpression). Measurements and Main Results: We document here extensive SP-B and -C (surfactant protein-B and -C) processing defects in IPF AEC2s, due to loss of Napsin A, resulting in increased intra-alveolar surface tension and alveolar collapse and induction of endoplasmic reticulum stress in AEC2s. In vivo pharmacological inhibition of Napsin A results in the development of AEC2 injury and overt lung fibrosis. We also demonstrate that Notch1 signaling is already activated early in IPF and determines AEC2 fate by inhibiting differentiation (reduced lamellar body compartment, reduced capacity to process hydrophobic SP) and by causing increased epithelial proliferation and development of lung fibrosis, putatively via altered JAK (Janus kinase)/Stat (signal transducer and activator of transcription) signaling in AEC2s. Conversely, inhibition of Notch signaling in IPF-derived precision-cut lung slices improved the surfactant processing capacity of AEC2s and reversed fibrosis. Conclusions: Notch1 is a central regulator of AEC2 fate in IPF. It induces alveolar epithelial proliferation and loss of Napsin A and of surfactant proprotein processing, and it contributes to fibroproliferation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
interstitial lung disease; diffuse parenchymal lung disease; lung surfactant; epithelial regeneration; idiopathic pulmonary fibrosis; Alveolar Type-ii; C-based Surfactant; Signaling Controls; Lung Development; Stem-cells; Differentiation; Pneumonitis; Expression; Quantification; Regeneration
Keywords plus
Language
english
Publication Year
2023
Prepublished in Year
0
HGF-reported in Year
2023
ISSN (print) / ISBN
1073-449X
e-ISSN
1535-4970
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 207,
Issue: 3,
Pages: 283-299
Article Number: ,
Supplement: ,
Series
Publisher
American Thoracic Society
Publishing Place
25 Broadway, 18 Fl, New York, Ny 10004 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Lung Research
PSP Element(s)
G-503100-001
Grants
Lung Fibrosis Foundation Waldhof-Elgershausen
European Commission
German Ministry of Science and Education (German Center for Lung Research, DA DPLD Funds)
Copyright
Erfassungsdatum
2024-01-16